Lipomics Technologies Inc., of Sacramento, Calif., hired Rebecca Baillie as senior research biologist.
Maxim Pharmaceuticals Inc., of San Diego, named Anne Kessler to its scientific and development advisory board as chair. Other members include Roger Guillemin, Clive Meanwell, John Glaspy, Douglas Green and Eugene Schiff.
MediQuest Therapeutics Inc., of Seattle, added Tyler Ellison as vice president, business development.
Odyssey Thera Inc., of San Ramon, Calif., added Aaron Solomon as vice president, business development.
ParAllele BioScience, of South San Francisco, added Andre Marion to its board.
Proneuron Biotechnologies Inc., of Los Angeles, appointed David Snyder vice president, clinical development.